Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Wire Cambodia.
Press releases published on August 7, 2025
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …
Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC
GlobeNewswire
·
August 7, 2025
6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with updates expected at 9 and 12 month data follow-up. …
AvePoint Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Total quarterly revenue surpassed $100 million for the first time Second quarter SaaS revenue of $77.3 million, representing 44% year-over-year growth, 40% on a constant currency basis Second quarter Total revenue of $102.0 million, representing 31% year- …
Synaptics Reports Fourth Quarter and Full Year Fiscal 2025 Results
GlobeNewswire
·
August 7, 2025
Fiscal 2025 revenue grew 12.0%, fueled by 53% growth in Core IoT product sales Synaptics' Board of Directors approved a new share repurchase program of up to $150 million Fiscal 2025 Financial Highlights Revenue of $1.074 billion increased 12% year-over- …
Commerce to Host Sell-side Analyst Q&A Session at Upcoming BigSummit
GlobeNewswire
·
August 7, 2025
AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver …
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Phase 2b NAVIGATE clinical trial evaluating CD388 for the prevention of seasonal influenza met primary and all secondary efficacy endpoints for all dose groups End of Phase 2 meeting request submitted to the U.S. Food and Drug Administration (FDA) Closed …
Key Tronic Corporation Announces Fourth Quarter Reporting and Annual Meeting Date
GlobeNewswire
·
August 7, 2025
SPOKANE VALLEY, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), announced today that it plans to report its results for the fourth quarter and full year ended of fiscal 2025 after market close on August 27, 2025. Key Tronic …
scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
Generated net FUROSCIX® revenue of $16 million in the second quarter of 2025; up 99% over Q2 2024 Doses shipped to patients increased 45% over Q1 2025 and 117% over Q2 2024 Launch of FUROSCIX in chronic kidney disease Autoinjector remains on track for sNDA …
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
GlobeNewswire
·
August 7, 2025
$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) …
Galapagos Creates New Subscription Right Plan
GlobeNewswire
·
August 7, 2025
Mechelen, Belgium; August 7, 2025, 22.01 CET; regulated information – Galapagos NV (Euronext …
Galapagos creëert nieuw inschrijvingsrechtenplan
GlobeNewswire
·
August 7, 2025
Mechelen, België; 7 augustus 2025, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext …
Celldex Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 7, 2025
Strong execution and continued progress across pipeline Unprecedented data delivered from Phase 2 CSU study demonstrating profound, sustained complete response and improved quality of life 7 months after completion of barzolvolimab dosing Data anticipated …
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
GlobeNewswire
·
August 7, 2025
Q2 revenue of $29.2 million, increased 55% year-over-year Q2 gross profit increased 59% year-over-year to $18.6 million Paid down $4.5 million of principal on outstanding term loan during Q2 Increased full year 2025 guidance to a revenue range between $104 …
Skye Bioscience Reports Second Quarter 2025 Financial Results and Business Update
GlobeNewswire
·
August 7, 2025
Reiterate top-line data readout from CBeyond™ Phase 2a study of nimacimab planned late Q3/early Q4 2025 Patient enrollment in Skye’s CBeyondTM Phase 2a obesity trial extension study initiated Independent Data Safety Monitoring Committee completed fourth …
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug …
CompoSecure Reports Record Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Operating results exceed expectations across all key metrics Strong top line growth driven by domestic programs from traditional banks and fintechs Record profitability demonstrates early results from CompoSecure Operating System Raising previously issued …
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Soquelitinib data from cohort 3 of atopic dermatitis Phase 1 clinical trial demonstrates earlier and deeper responses compared to cohorts 1-2 along with clinically meaningful reduction in itch as early as day 8 Enrollment ongoing in Phase 1 trial extension …
Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
Successfully launched AYON Body Contouring System™ to key surgeons in critical geographies; plan for commercial launch in September 2025 Initiated commercial sales of Renuvion® in China with strong clinical interest and completed initial procedures Based …
Turtle Beach Corporation Announces Second Quarter 2025 Financial Results and Reiterates Full Year Guidance
GlobeNewswire
·
August 7, 2025
–Delivered Net Revenue of $56.8 Million– –Gross Margin Improved to 32.2%, an Increase of 200 Basis Points Compared to Prior Year– –Net Loss of $2.9 Million Compared to Net Loss of $7.5 Million in Prior Year– –Adjusted EBITDA of ($3.0) Million– –Refinanced …
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results
GlobeNewswire
·
August 7, 2025
Phase 2 MaGic trial of claseprubart (DNTH103) in generalized Myasthenia Gravis (gMG) top-line results anticipated in September 2025; the first of three catalysts for the claseprubart neuromuscular franchise by YE’26 Phase 3 CAPTIVATE trial of claseprubart …